Dose adjustment of drugs with high hepatic extraction are required in patients with severe liver disease

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.22, Iss.5, 2006-05, pp. : 23-26

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dose Adjustment in Patients with Liver Disease

By Delcò Fabiola Tchambaz Lydia Schlienger Raymond Drewe Jürgen Krähenbühl Stephan

Drug Safety, Vol. 28, Iss. 6, 2005-01 ,pp. : 529-545

Adis International

Access to resources Recommend Favorite

Dose Adaptation of Antineoplastic Drugs in Patients with Liver Disease

By Tchambaz Lydia

Drug Safety, Vol. 29, Iss. 6, 2006-01 ,pp. : 509-522

Adis International

Access to resources Recommend Favorite

Pharmacokinetic Changes of Psychotropic Drugs in Patients with Liver Disease: Implications for Dose Adaptation

By Schlatter Chantal Egger Sabin S. Tchambaz Lydia Krähenbühl Stephan

Drug Safety, Vol. 32, Iss. 7, 2009-07 ,pp. : 561-578

Adis International

Access to resources Recommend Favorite

Hepatic Effects of Lovastatin Exposure in Patients with Liver Disease: A Retrospective Cohort Study

By Avins Andrew L. Manos Michele M. Ackerson Lynn

Drug Safety, Vol. 31, Iss. 4, 2008-01 ,pp. : 325-334

Adis International

Access to resources Recommend Favorite

Endocannabinoids in Liver Disease and Hepatic Encephalopathy

Current Pharmaceutical Design, Vol. 14, Iss. 23, 2008-08 ,pp. : 2362-2369

Bentham Science Publishers

Access to resources Recommend Favorite